Samuel W. Du

Samuel W. Du

Auto-generated profile, based on publicly available information

Samuel W. Du

Gavin Herbert Eye Institute - Brunson Center for Translational Vision Research, Department of Ophthalmology, University of California, Irvine, Irvine, CA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2022 in Cell
Verified
Journal Article
Open access
SBSamagya Banskota
Samagya Banskota
ARAditya Raguram
Aditya Raguram
SSSusie Suh
Susie Suh
SDSamuel W. Du
Samuel W. Du
JDJessie R. Davis
Jessie R. Davis
DLDavid R. Liu
David R. Liu
Methods to deliver gene editing agents in vivo as ribonucleoproteins could offer safety advantages over nucleic acid delivery approaches. We report the development and application of engineered DNA-free virus-like particles (eVLPs) that efficiently package and deliver base editor or Cas9 ribonucleoproteins. By engineering VLPs to overcome cargo packaging, release, and localization bottlenecks, we developed fourth-generation eVLPs that mediate efficient base editing in several primary mouse and human cell types. Using different glycoproteins in eVLPs alters their cellular tropism. Single injections of eVLPs into mice support therapeutic levels of base editing in multiple tissues, reducing serum Pcsk9 levels 78% following 63% liver editing, and partially restoring visual function in a mouse model of genetic blindness. In vitro and in vivo off-target editing from eVLPs was virtually undetected, an improvement over AAV or plasmid delivery. These results establish eVLPs as promising vehicles for therapeutic macromolecule delivery that combine key advantages of both viral and nonviral delivery.

8 January 2024 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
MAMeirui An
Meirui An
ARAditya Raguram
Aditya Raguram
SDSamuel W. Du
Samuel W. Du
SBSamagya Banskota
Samagya Banskota
JDJessie R. Davis
Jessie R. Davis
DLDavid R. Liu
David R. Liu
Prime editing enables precise installation of genomic substitutions, insertions and deletions in living systems. Efficient in vitro and in vivo delivery of prime editing components, however, remains a challenge. Here we report prime editor engineered virus-like particles (PE-eVLPs) that deliver prime editor proteins, prime editing guide RNAs and nicking single guide RNAs as transient ribonucleoprotein complexes. We systematically engineered v3 and v3b PE-eVLPs with 65- to 170-fold higher editing efficiency in human cells compared to a PE-eVLP construct based on our previously reported base editor eVLP architecture. In two mouse models of genetic blindness, single injections of v3 PE-eVLPs resulted in therapeutically relevant levels of prime editing in the retina, protein expression restoration and partial visual function rescue. Optimized PE-eVLPs support transient in vivo delivery of prime editor ribonucleoproteins, enhancing the potential safety of prime editing by reducing off-target editing and obviating the possibility of oncogenic transgene integration.

12 September 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TATanvi Arkatkar
Tanvi Arkatkar
SDSamuel W. Du
Samuel W. Du
HJHolly M. Jacobs
Holly M. Jacobs
EDElizabeth M. Dam
Elizabeth M. Dam
BHBaidong Hou
Baidong Hou
SJShaun W. Jackson
Shaun W. Jackson
Recent studies have identified critical roles for B cells in triggering autoimmune germinal centers (GCs) in systemic lupus erythematosus (SLE) and other disorders. The mechanisms whereby B cells facilitate loss of T cell tolerance, however, remain incompletely defined. Activated B cells produce interleukin 6 (IL-6), a proinflammatory cytokine that promotes T follicular helper (TFH) cell differentiation. Although B cell IL-6 production correlates with disease severity in humoral autoimmunity, whether B cell–derived IL-6 is required to trigger autoimmune GCs has not, to our knowledge, been addressed. Here, we report the unexpected finding that a lack of B cell–derived IL-6 abrogates spontaneous GC formation in mouse SLE, resulting in loss of class-switched autoantibodies and protection from systemic autoimmunity. Mechanistically, B cell IL-6 production was enhanced by IFN-γ, consistent with the critical roles for B cell–intrinsic IFN-γ receptor signals in driving autoimmune GC formation. Together, these findings identify a key mechanism whereby B cells drive autoimmunity via local IL-6 production required for TFH differentiation and autoimmune GC formation.

28 November 2024 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
RHRafał Hołubowicz
Rafał Hołubowicz
SDSamuel W. Du
Samuel W. Du
JFJiin Felgner
Jiin Felgner
RSRoman Smidak
Roman Smidak
ECElliot H. Choi
Elliot H. Choi
KPKrzysztof Palczewski
Krzysztof Palczewski
Delivering ribonucleoproteins (RNPs) for in vivo genome editing is safer than using viruses encoding for Cas9 and its respective guide RNA. However, transient RNP activity does not typically lead to optimal editing outcomes. Here we show that the efficiency of delivering RNPs can be enhanced by cell-penetrating peptides (covalently fused to the protein or as excipients) and that lipid nanoparticles (LNPs) encapsulating RNPs can be optimized for enhanced RNP stability, delivery efficiency and editing potency. Specifically, after screening for suitable ionizable cationic lipids and by optimizing the concentration of the synthetic lipid DMG-PEG 2000, we show that the encapsulation, via microfluidic mixing, of adenine base editor and prime editor RNPs within LNPs using the ionizable lipid SM102 can result in in vivo editing-efficiency enhancements larger than 300-fold (with respect to the delivery of the naked RNP) without detectable off-target edits. We believe that chemically defined LNP formulations optimized for RNP-encapsulation stability and delivery efficiency will lead to safer genome editing.

5 April 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ECElliot H. Choi
Elliot H. Choi
SSSusie Suh
Susie Suh
AFAndrzej T. Foik
Andrzej T. Foik
HLHenri Leinonen
Henri Leinonen
GNGregory A. Newby
Gregory A. Newby
KPKrzysztof Palczewski
Krzysztof Palczewski
Leber congenital amaurosis (LCA) is the most common cause of inherited retinal degeneration in children. LCA patients with RPE65 mutations show accelerated cone photoreceptor dysfunction and death, resulting in early visual impairment. It is therefore crucial to develop a robust therapy that not only compensates for lost RPE65 function but also protects photoreceptors from further degeneration. Here, we show that in vivo correction of an Rpe65 mutation by adenine base editor (ABE) prolongs the survival of cones in an LCA mouse model. In vitro screening of ABEs and sgRNAs enables the identification of a variant that enhances in vivo correction efficiency. Subretinal delivery of ABE and sgRNA corrects up to 40% of Rpe65 transcripts, restores cone-mediated visual function, and preserves cones in LCA mice. Single-cell RNA-seq reveals upregulation of genes associated with cone phototransduction and survival. Our findings demonstrate base editing as a potential gene therapy that confers long-lasting retinal protection.

24 October 2018 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
SDSamuel W. Du
Samuel W. Du
TATanvi Arkatkar
Tanvi Arkatkar
HJHolly M. Jacobs
Holly M. Jacobs
DRDavid J. Rawlings
David J. Rawlings
SJShaun W. Jackson
Shaun W. Jackson
Age‐associated B cells (ABC), a novel subset of activated B cells defined by CD11b and CD11c expression, have been linked with both protective anti‐viral responses and the pathogenesis of systemic autoimmunity. Expression of the TH1 lineage transcription factor T‐bet has been identified as a defining feature of ABC biology, with B cell‐intrinsic expression of this transcription factor proposed to be required for ABC formation. In contrast to this model, we report that Tbx21 (encoding T‐bet)‐deficient B cells upregulate CD11b and CD11c surface expression in vitro in response to integrated TLR and cytokine signals. Moreover, B cell‐intrinsic T‐bet deletion in a murine lupus model exerted no impact of ABC generation in vivo, with Tbx21−/− ABCs exhibiting an identical surface phenotype to wild‐type (WT) ABCs. Importantly, WT and Tbx21−/− ABCs sorted from autoimmune mice produced equivalent amounts of IgM and IgG ex vivo following TLR stimulation, indicating that T‐bet‐deficient ABCs are likely functional in vivo. In summary, our data contradict the established literature by demonstrating that T‐bet expression is not uniformly required for ABC generation.